*You are now in the CME section of our website
Combined Use of Neurotoxins (BoNTA) & Dermal Fillers for Facial Enhancement: Advanced Techniques
This comprehensive 8.5 hour hands-on aesthetic instructional course details the latest cosmetic applications and techniques utilized by respected and expert international injectors of Neurotoxins (BoNTA) and Dermal Fillers. This doctor and nurse injector training is offered to medical professionals having a minimum of 6 months experience routinely injecting any of the FDA approved cosmetic neurotoxin or dermal filler products, and who have a desire to expand their skills and increase their aesthetic practice.
Sample Program Agenda
Course content consists of:
Morning lecture focusing on principles and practices for achieving optimal results for facial shaping as well as wrinkle/crease reduction and facial rejuvenation.
- Step-by-step instruction for successful and safe treatment of appropriate sites of the upper and lower face and neck is provided.
- In-depth education and interactive review of facial anatomy and physiology equip you to confidently determine the best treatment plan utilizing Neurotoxins (BoNTA) and Dermal Fillers. Discussion about how to most effectively combine Neurotoxins (BoNTA) and Dermal Fillers with other non-surgical modalities for total rejuvenation is provided.
Afternoon is dedicated to hands-on injecting experience, learning advanced techniques using both Neurotoxins (BoNTA) and Dermal Filler products. Our highly qualified instructors provide one-on-one teaching that is tailored to your existing experience as an injector. AAI’s limited class size ensures each clinician receives optimal time to practice new techniques and build confidence in treating sites new to their experience.
This Instructional Course offers review and perfection of techniques for the traditional, FDA-approved sites, such as glabellar creases, nasolabial folds and hyperhidrosis, as well as the additional off-label sites listed below:
Dermal Filler Sites for Injection (discussed in detail during lecture)
*Indicates off-label site
- lip augmentation (vermilion border and vermilion)* (FDA approved for Restylane L, Restylane Silk and Juvederm Ultra)
- nasolabial folds
- mandibular grooves (jowls)
- marionette lines/oral commissures
- chin augmentation*
- cheek augmentation* (FDA approved for Voluma)
- tear trough deformity*
- brow lift/augmentation*
- earlobe rejuvenation*
- perioral fine lines
- nasal sculpting*
- instructor will assess participants’ readiness for treating these areas and assist in determining if patients are appropriate candidates for treatment
Neurotoxins (BoNTA) (dicussed in detail in lecture):
- glabella frown lines
- horizontal forehead lines*
- crow’s feet
- brow lift (medial & lateral brow depressors)*
- bunny lines of the nose (nasalis)*
- lower lids (orbicularis oculi)*
- nasal tip elevation (depressor septi)*
- gummy smile (LLSAN)*
- smoker’s lines of the mouth (orbicularis oris)*
- lip augmentation (orbicularis oris)*
- down-turned mouth (depressor anguli oris)*
- mental crease/peu d’ orange/dimpling of the chin (mentalis)*
- horizontal neck lines (neck accessory muscles)*
- platysmal neck bands (platysma)*
- square jaw (masseter)*
Upon successful completion of the activities, participants will be able to:
- Review evidence-based basic injection techniques as well as introduce evidence-based alternative injection techniques of routinely injected treatment sites to their practice.
- Apply evidence-based principles and techniques for optimal facial enhancement for injecting neurotoxins and dermal fillers to injection sites not previously injected.
- Be able to recognize and implement appropriate treatment protocol of potential adverse events at treatment sites not previously injected.
Method of Participation
Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claimed credit form available at www.akhcme.com/aai. To avoid issues with your spam filter, please list email@example.com as an approved email address.
If you have questions about this CME activity, please contact AKH Inc. at firstname.lastname@example.org.
CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Aesthetic Advancements Inc.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category I Credit(s)™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education and nurse injector training by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 8.5 contact hours.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.
Provider Number: 030803.
This activity is awarded 8.5 contact hours which includes 0 hours of pharmacology. Program ID #21524.
There is no commercial support of this activity
It is the policy of AKH Inc. and AAI to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
AKH Inc. and AAI planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
*Program subject to change.